NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note
DURHAM, N.C., Jan. 30, 2024 (GLOBE NEWSWIRE) — NightHawk Biosciences (NYSE American: NHWK) (“NightHawk” or the “Company”), an integrated contract […]